🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the optimal use, efficacy, and safety of a Trea...
Status
Completed
Location
Multiple Locations
Start Date
2015-11-19
Trial ID
NCT02581891
Comparison of efficacy and safety of Mitomycin and Aflibercept used to supp...
Status
Completed
Location
Medical University of Lublin
Start Date
2017-06-14
Trial ID
NCT03766425
Treatments Being Tested
Phase 2 open label, randomized, active controlled, dose-ranging trial in ad...
Status
Recruiting
Location
Sierra Eye Associates
Start Date
2025-03-18
Trial ID
NCT06942520
Treatments Being Tested
The purpose of this study is to compare brolucizumab (RTH258) ophthalmic so...
Status
Completed
Location
Contact Alcon Call Center for Trial Locations
Start Date
2014-12-08
Trial ID
NCT02307682
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of X-82 in...
Status
Terminated
Location
Multiple Locations
Start Date
2015-03-16
Trial ID
NCT02348359
The centre of the retina (macula) at the back of the eye contains cells tha...
Status
Recruiting
Location
University of Bonn
Start Date
2021-04-16
Trial ID
NCT04663750
Treatments Being Tested
The purpose of this Phase II study will be to investigate the antiangiogeni...
Status
Completed
Location
Florida Cancer Specialists
Start Date
2013-01
Trial ID
NCT01749956
Treatments Being Tested
The AMALTHEA (Aflibercept MAintenance after first-Line THErapy with FOLFIRI...
Status
Completed
Location
Agios Georgios Chania General Hospital
Start Date
2014-05-26
Trial ID
NCT02129257
Treatments Being Tested
The investigators hypothesize that patients with mCRC RAS-mutant eligible f...
Status
Recruiting
Location
Istituto Nazionale Tumori | "Fondazione Pascale"
Start Date
2025-10-16
Trial ID
NCT07213570
Treatments Being Tested
Oculgen has begun a study of an investigational drug called OCUL101 as a po...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-17
Trial ID
NCT07520318
Treatments Being Tested